Continuous glucose monitoring in type 1 diabetes
- PMID: 15035968
- DOI: 10.1007/s11892-004-0063-z
Continuous glucose monitoring in type 1 diabetes
Abstract
Continuous glucose monitoring is becoming increasingly more widespread for the routine care of people with type 1 diabetes mellitus and may eventually be used in closed-loop artificial beta-cell systems. The current "state of the art" of this technology, including accuracy, performance in clinical trials, limitations, and recommendations for use, is discussed for the two currently approved continuous glucose monitoring devices.
References
Publication types
MeSH terms
Substances
Grants and funding
- HD041-15/HD/NICHD NIH HHS/United States
- HD041890/HD/NICHD NIH HHS/United States
- HD041906-01/HD/NICHD NIH HHS/United States
- HD041908-01/HD/NICHD NIH HHS/United States
- HD041918-01/HD/NICHD NIH HHS/United States
- HD041919-0/HD/NICHD NIH HHS/United States
- M01 RR00069/RR/NCRR NIH HHS/United States
- RR00059/RR/NCRR NIH HHS/United States
- RR00070-41/RR/NCRR NIH HHS/United States
- RR06022/RR/NCRR NIH HHS/United States
- U01 HD041890-03/HD/NICHD NIH HHS/United States
- U10 HD041906-03/HD/NICHD NIH HHS/United States
- U10 HD041908-03/HD/NICHD NIH HHS/United States
- U10 HD041915-03/HD/NICHD NIH HHS/United States
- U10 HD041918-03/HD/NICHD NIH HHS/United States
- U10 HD041919-03/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical